More on RNA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.2 Score)
- Holders
- Event Driven Deals

Upcoming Events

- Earnings (9/2/26)
- M&A (3/31/15 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Avidity Biosciences Inc. (NQ:RNA)
Delayed: 12.37 -0.06 (0.48%)
Prev. Close $12.43  
Open$12.43 
52 Wk High$22.80 
52 Wk Low$4.12 
Day High$12.47 
Day Low$12.16 
P/E N/A  
EPS$0.00 
Volume103,635 

Friends, Peers and Foes (?): RNAM, DYN, NVS, PTCT, BHVN (more...)

May 15, 2026 06:08 AM Leerink Partners Starts Atrium Therapeutics (RNA) at Outperform
May 14, 2026 04:40 PM Atrium Therapeutics Reports First Quarter 2026 Financial Results
Apr 23, 2026 08:01 AM Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb
Apr 23, 2026 08:00 AM Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Apr 20, 2026 10:46 PM Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 10, 2026 04:24 PM Wells Fargo Starts Avidity Biosciences (RNA) at Overweight
Feb 27, 2026 03:29 PM Form 4 Avidity Biosciences, For: Feb 27 Filed by: McCarthy Teresa
Feb 27, 2026 03:27 PM Form 4 Avidity Biosciences, For: Feb 27 Filed by: Thompson Tamar
Feb 27, 2026 03:25 PM Form 4 Avidity Biosciences, For: Feb 27 Filed by: MacLean Michael F
Feb 27, 2026 03:23 PM Form 4 Avidity Biosciences, For: Feb 27 Filed by: Skerjanec Simona
View All Articles

Entities mentioned with RNA

View All Entities